• KD Pharma Acquires Rohner AG Manufacturing Assets contractpharma
    March 30, 2021
    ​The KD Pharma Group has acquired the manufacturing assets of the former Rohner AG. The assets give KD Pharma access to new complementary technologies that will allow the company to further expand its pharmaceutical CDMO business.
  • Chime Biologics Expands CDMO Capabilities contractpharma
    March 30, 2021
  • mAbxience Expands Biosimilar and CDMO Manufacturing Capacity contractpharma
    March 26, 2021
  • Chime Biologics announces Marc Funk as new Board Director prnasia
    March 22, 2021
    Chime Biologics is pleased to announce the appointment of Marc Funk to its Board of Directors. Marc brings more than 20 years of leadership and industry experience in the global CDMO space.
  • Alcami Names Patrick D. Walsh as Chairman and CEO contractpharma
    March 22, 2021
  • Fujifilm Selects North Carolina for $2B Bio CDMO Facility contractpharma
    March 22, 2021
  • ANI Pharmaceuticals Strengthens CDMO Biz contractpharma
    March 12, 2021
    ​ANI Pharmaceuticals has struck a $163.5 million deal to acquire Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities.
  • Altasciences Doubles Size of PA CDMO Facility contractpharma
    March 11, 2021
    The additional 35,000-sq.-ft. building in Philadelphia will include warehouse and cGMP manufacturing suites.
  • Charles River Acquires CDMO Cognate BioServices contractpharma
    February 18, 2021
  • Wacker Strengthens Biologics Business contractpharma
    February 05, 2021
PharmaSources Customer Service